IDDI at Biomarker and Companion Diagnostics Virtual Conference
October 20, 2020 — October 23, 2020
Leveraging next gen technologies beyond conventional biomarker drug discovery
The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials. The conference will address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.
Join IDDI at the The Biomarker and Companion Diagnostics Virtual Conference
IDDI HAS LONG-STANDING EXPERIENCE IN IDENTIFYING AND
VALIDATING (ANALYTICAL AND CLINICAL VALIDATION) SINGLE BIOMARKERS, BIOMARKER PROFILES, AND IVDS!
MEET:
- Vicky Martin our Sr Director BD US. Want to set up a meeting ? Contact her at vicky.martin@iddi.signalsuite.com
- Robert Whitaker our Director, Business Development, West Coast USA. Want to set up a meeting ? Contact him at robert.whitaker@iddi.signalsuite.com.
- Erik Falvey our Sr Director BD Europe. Want to set up a meeting ? Contact him at erik.falvey@iddi.signalsuite.com
